Puyang Refractories Group Valuation
Is 2225 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 2225 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 002225 (CN¥4.61) is trading below our estimate of fair value (CN¥10.38)
Significantly Below Fair Value: 002225 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2225?
Other financial metrics that can be useful for relative valuation.
What is 2225's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CN¥4.58b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.1x |
Enterprise Value/EBITDA | 15.7x |
PEG Ratio | 1.2x |
Price to Earnings Ratio vs Peers
How does 2225's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 56.2x | ||
300891 Guangdong Huiyun Titanium Industry | 77.7x | n/a | CN¥4.0b |
300566 Ningbo Exciton Technology | 23.5x | 23.1% | CN¥3.9b |
600792 Yunnan Coal & EnergyLtd | 106.7x | n/a | CN¥4.2b |
605166 Hangzhou Juheshun New MaterialLTD | 17x | 28.6% | CN¥3.7b |
002225 Puyang Refractories Group | 17x | 14.0% | CN¥4.6b |
Price-To-Earnings vs Peers: 002225 is good value based on its Price-To-Earnings Ratio (17x) compared to the peer average (56.2x).
Price to Earnings Ratio vs Industry
How does 2225's PE Ratio compare vs other companies in the CN Chemicals Industry?
Price-To-Earnings vs Industry: 002225 is good value based on its Price-To-Earnings Ratio (17x) compared to the CN Chemicals industry average (34.1x).
Price to Earnings Ratio vs Fair Ratio
What is 2225's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 17x |
Fair PE Ratio | 15.5x |
Price-To-Earnings vs Fair Ratio: 002225 is expensive based on its Price-To-Earnings Ratio (17x) compared to the estimated Fair Price-To-Earnings Ratio (15.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.